Importer of Controlled Substances Application: Cerilliant Corporation, 53924-53926 [2023-17037]

Download as PDF 53924 Federal Register / Vol. 88, No. 152 / Wednesday, August 9, 2023 / Notices importer of the following basic class(es) of controlled substance(s): Controlled substance Hydromorphone ............ Morphine ....................... Drug code 9150 9300 DEPARTMENT OF JUSTICE Drug Enforcement Administration Schedule [Docket No. DEA–1240] II II Importer of Controlled Substances Application: Cerilliant Corporation Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: The company plans to import the listed controlled substances for analytical purpose only. No other activities for these drug codes are authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Claude Redd, Acting Deputy Assistant Administrator. [FR Doc. 2023–17035 Filed 8–8–23; 8:45 am] BILLING CODE 4410–09–P Cerilliant Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before September 8, 2023. Such persons may also file a written request for a hearing on the application on or before September 8, 2023. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for SUMMARY: lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on July 10, 2023, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665–2402, applied to be registered as an importer of the following basic class(es) of controlled substance(s): lotter on DSK11XQN23PROD with NOTICES1 Controlled substance Drug code 3-Fluoro-N-methylcathinone (3-FMC) .............................................................................................................................. Cathinone ........................................................................................................................................................................ Methcathinone ................................................................................................................................................................. 4-FMC; FLEPHEDRONE; 1-( 4-FLUOROPHENYL)-2-(METHYLAMINO )PROPAN-1-ONE) ........................................ Pentedrone (a-methylaminovalerophenone) ................................................................................................................... Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 4-Methyl-N-ethylcathinone (4-MEC) ................................................................................................................................ Naphyrone ....................................................................................................................................................................... N-Ethylamphetamine ....................................................................................................................................................... N,N-Dimethylamphetamine .............................................................................................................................................. Fenethylline ..................................................................................................................................................................... Methaqualone .................................................................................................................................................................. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ................................................................................................... SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ................................................. 5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ................. AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ...................... JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ....................................................................................................................... AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .......................................... THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) ................................................................. AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ................ ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .................................. APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ............................................................ JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ................................................................................................... SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) ..................................................................... JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ...................................................................................................... UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .................................................................. JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ........................................................................................................................ JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ........................................................................................... AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ....................................................................................................... JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...................................................................................................... PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) .................................................................................................. 5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) .............................................................................. Alpha-ethyltryptamine ...................................................................................................................................................... Ibogaine ........................................................................................................................................................................... VerDate Sep<11>2014 18:19 Aug 08, 2023 Jkt 259001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\09AUN1.SGM 09AUN1 1233 1235 1237 1238 1246 1248 1249 1258 1475 1480 1503 2565 6250 7008 7011 7012 7019 7023 7024 7031 7035 7048 7081 7104 7118 7122 7144 7173 7200 7201 7203 7222 7225 7249 7260 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 53925 Federal Register / Vol. 88, No. 152 / Wednesday, August 9, 2023 / Notices lotter on DSK11XQN23PROD with NOTICES1 Controlled substance Drug code CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................. CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ........................................... Lysergic acid diethylamide .............................................................................................................................................. 2C-T-7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine ................................................................................................. Marihuana ........................................................................................................................................................................ Parahexyl ......................................................................................................................................................................... Mescaline ......................................................................................................................................................................... 2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine ) ............................................................................................ 3,4,5-Trimethoxyamphetamine ........................................................................................................................................ 4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 4-Bromo-2,5-dimethoxyphenethylamine .......................................................................................................................... 4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................. 2,5-Dimethoxyamphetamine ............................................................................................................................................ JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ...................................................................................................... 3,4-Methylenedioxyamphetamine .................................................................................................................................... 5-Methoxy-3,4-methylenedioxyamphetamine .................................................................................................................. N-Hydroxy-3,4-methylenedioxyamphetamine .................................................................................................................. 3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 3,4-Methylenedioxymethamphetamine ............................................................................................................................ 4-Methoxyamphetamine .................................................................................................................................................. 5-Methoxy-N-N-dimethyltryptamine ................................................................................................................................. Alpha-methyltryptamine ................................................................................................................................................... Bufotenine ........................................................................................................................................................................ Diethyltryptamine ............................................................................................................................................................. Dimethyltryptamine .......................................................................................................................................................... Psilocybin ......................................................................................................................................................................... Psilocyn ........................................................................................................................................................................... 5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................. N-Ethyl-1-phenylcyclohexylamine .................................................................................................................................... 1-(1-Phenylcyclohexyl)pyrrolidine .................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]piperidine ............................................................................................................................... N-Benzylpiperazine .......................................................................................................................................................... 4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) ..................................................................................................... 2C-D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) .................................................................................................. 2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) ...................................................................................................... 2C-H 2-(2,5-Dimethoxyphenyl) ethanamine) ................................................................................................................... 2C-I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) .......................................................................................................... 2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) .................................................................................................... 2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) ..................................................................................................... 2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) .............................................................................................. 2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) ..................................................................................... MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... 25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ..................................................... 25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ..................................................... 25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) .......................................................... Methylone (3,4-Methylenedioxy-N-methylcathinone) ...................................................................................................... Butylone ........................................................................................................................................................................... Pentylone ......................................................................................................................................................................... alpha-pyrrolidinopentiophenone (a-PVP) ........................................................................................................................ alpha-pyrrolidinobutiophenone (a-PBP) .......................................................................................................................... AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) .................................................................................................... Desomorphine ................................................................................................................................................................. Etorphine (except HCl) .................................................................................................................................................... Codeine methylbromide ................................................................................................................................................... Heroin .............................................................................................................................................................................. Morphine-N-oxide ............................................................................................................................................................ Normorphine .................................................................................................................................................................... Pholcodine ....................................................................................................................................................................... U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ............................................................... AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) .................................................................. Acetylmethadol ................................................................................................................................................................ Allylprodine ...................................................................................................................................................................... Alphacetylmethadol except levo-alphacetylmethadol ...................................................................................................... Alphameprodine ............................................................................................................................................................... Alphamethadol ................................................................................................................................................................. Betacetylmethadol ........................................................................................................................................................... Betameprodine ................................................................................................................................................................ Betamethadol ................................................................................................................................................................... Betaprodine ..................................................................................................................................................................... Dextromoramide .............................................................................................................................................................. Dipipanone ....................................................................................................................................................................... Hydroxypethidine ............................................................................................................................................................. Noracymethadol ............................................................................................................................................................... Norlevorphanol ................................................................................................................................................................ VerDate Sep<11>2014 18:19 Aug 08, 2023 Jkt 259001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 E:\FR\FM\09AUN1.SGM 09AUN1 7297 7298 7315 7348 7360 7374 7381 7385 7390 7391 7392 7395 7396 7398 7400 7401 7402 7404 7405 7411 7431 7432 7433 7434 7435 7437 7438 7439 7455 7458 7470 7493 7498 7508 7509 7517 7518 7519 7521 7524 7532 7535 7536 7537 7538 7540 7541 7542 7545 7546 7694 9055 9056 9070 9200 9307 9313 9314 9547 9551 9601 9602 9603 9604 9605 9607 9608 9609 9611 9613 9622 9627 9633 9634 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 53926 Federal Register / Vol. 88, No. 152 / Wednesday, August 9, 2023 / Notices Controlled substance Drug code Normethadone ................................................................................................................................................................. Racemoramide ................................................................................................................................................................ Trimeperidine ................................................................................................................................................................... 1-Methyl-4-phenyl-4-propionoxypiperidine ...................................................................................................................... Tilidine ............................................................................................................................................................................. Para-Fluorofentanyl ......................................................................................................................................................... 3-Methylfentanyl .............................................................................................................................................................. Alpha-methylfentanyl ....................................................................................................................................................... Acetyl-alpha-methylfentanyl ............................................................................................................................................. Beta-hydroxyfentanyl ....................................................................................................................................................... Beta-hydroxy-3-methylfentanyl ........................................................................................................................................ Alpha-methylthiofentanyl ................................................................................................................................................. 3-Methylthiofentanyl ......................................................................................................................................................... Thiofentanyl ..................................................................................................................................................................... Fentanyl related-compounds as defined in 21 CFR 1308.11(h) ..................................................................................... Methamphetamine ........................................................................................................................................................... Methylphenidate .............................................................................................................................................................. Amobarbital ...................................................................................................................................................................... Pentobarbital .................................................................................................................................................................... Secobarbital ..................................................................................................................................................................... Glutethimide ..................................................................................................................................................................... Nabilone ........................................................................................................................................................................... 1-Phenylcyclohexylamine ................................................................................................................................................ Phencyclidine ................................................................................................................................................................... Phenylacetone ................................................................................................................................................................. 1-Piperidinocyclohexanecarbonitrile ................................................................................................................................ Alphaprodine .................................................................................................................................................................... Dihydrocodeine ................................................................................................................................................................ Ecgonine .......................................................................................................................................................................... Ethylmorphine .................................................................................................................................................................. Levomethorphan .............................................................................................................................................................. Levorphanol ..................................................................................................................................................................... Meperidine ....................................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. Levo-alphacetylmethadol ................................................................................................................................................. Noroxymorphone ............................................................................................................................................................. Racemethorphan ............................................................................................................................................................. Alfentanil .......................................................................................................................................................................... Remifentanil ..................................................................................................................................................................... Sufentanil ......................................................................................................................................................................... Carfentanil ....................................................................................................................................................................... Tapentadol ....................................................................................................................................................................... lotter on DSK11XQN23PROD with NOTICES1 The company plans to import the listed controlled substances for the manufacturing of analytical reference standards and distribution to their research and forensic customers. No other activities for these drug codes are authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Claude Redd, Acting Deputy Assistant Administrator. [FR Doc. 2023–17037 Filed 8–8–23; 8:45 am] BILLING CODE P VerDate Sep<11>2014 18:19 Aug 08, 2023 Jkt 259001 DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–1235] Importer of Controlled Substances Application: ANI Pharmaceuticals Inc. Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: ANI Pharmaceuticals Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before September 8, 2023. Such persons may also file a written request SUMMARY: PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 9635 9645 9646 9661 9750 9812 9813 9814 9815 9830 9831 9832 9833 9835 9850 1105 1724 2125 2270 2315 2550 7379 7460 7471 8501 8603 9010 9120 9180 9190 9210 9220 9230 9273 9648 9668 9732 9737 9739 9740 9743 9780 Schedule I I I I I I I I I I I I I I I II II II II II II II II II II II II II II II II II II II II II II II II II II II for a hearing on the application on or before September 8, 2023. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia E:\FR\FM\09AUN1.SGM 09AUN1

Agencies

[Federal Register Volume 88, Number 152 (Wednesday, August 9, 2023)]
[Notices]
[Pages 53924-53926]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-17037]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1240]


Importer of Controlled Substances Application: Cerilliant 
Corporation

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Cerilliant Corporation has applied to be registered as an 
importer of basic class(es) of controlled substance(s). Refer to 
Supplementary Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
September 8, 2023. Such persons may also file a written request for a 
hearing on the application on or before September 8, 2023.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment. All 
requests for a hearing must be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152. All requests for a hearing should also be 
sent to: Drug Enforcement Administration, Attn: Administrator, 8701 
Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on July 10, 2023, Cerilliant Corporation, 811 Paloma 
Drive, Suite A, Round Rock, Texas 78665-2402, applied to be registered 
as an importer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC).            1233  I
Cathinone..........................            1235  I
Methcathinone......................            1237  I
4-FMC; FLEPHEDRONE; 1-( 4-                     1238  I
 FLUOROPHENYL)-2-(METHYLAMINO
 )PROPAN-1-ONE).
Pentedrone ([alpha]-                           1246  I
 methylaminovalerophenone).
Mephedrone (4-Methyl-N-                        1248  I
 methylcathinone).
4-Methyl-N-ethylcathinone (4-MEC)..            1249  I
Naphyrone..........................            1258  I
N-Ethylamphetamine.................            1475  I
N,N-Dimethylamphetamine............            1480  I
Fenethylline.......................            1503  I
Methaqualone.......................            2565  I
JWH-250 (1-Pentyl-3-(2-                        6250  I
 methoxyphenylacetyl) indole).
SR-18 (Also known as RCS-8) (1-                7008  I
 Cyclohexylethyl-3-(2-
 methoxyphenylacetyl) indole).
5-Fluoro-UR-144 and XLR11 [1-(5-               7011  I
 Fluoro-pentyl)1H-indol-3-
 yl](2,2,3,3-
 tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1-            7012  I
 oxobutan-2-yl)-1-(4-fluorobenzyl)-
 1H-indazole-3-carboxamide).
JWH-019 (1-Hexyl-3-(1-                         7019  I
 naphthoyl)indole).
AB-PINACA (N-(1-amino-3-methyl-1-              7023  I
 oxobutan-2-yl)-1-pentyl-1H-
 indazole-3-carboxamide).
THJ-2201 ([1-(5-fluoropentyl)-1H-              7024  I
 indazol-3-yl](naphthalen-1-
 yl)methanone).
AB-CHMINACA (N-(1-amino-3-methyl-1-            7031  I
 oxobutan-2-yl)-1-
 (cyclohexylmethyl)-1H-indazole-3-
 carboxamide).
ADB-PINACA (N-(1-amino-3,3-dimethyl-           7035  I
 1-oxobutan-2-yl)-1-pentyl-1H-
 indazole-3-carboxamide).
APINACA and AKB48 (N-(1-Adamantyl)-            7048  I
 1-pentyl-1H-indazole-3-
 carboxamide).
JWH-081 (1-Pentyl-3-(1-(4-                     7081  I
 methoxynaphthoyl) indole).
SR-19 (Also known as RCS-4) (1-                7104  I
 Pentyl-3-[(4-methoxy)-benzoyl]
 indole).
JWH-018 (also known as AM678) (1-              7118  I
 Pentyl-3-(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1-               7122  I
 naphthoyl) indole).
UR-144 (1-Pentyl-1H-indol-3-                   7144  I
 yl)(2,2,3,3-
 tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1-                         7173  I
 naphthoyl)indole).
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-           7200  I
 3-(1-naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-               7201  I
 naphthoyl) indole).
JWH-203 (1-Pentyl-3-(2-                        7203  I
 chlorophenylacetyl) indole).
PB-22 (Quinolin-8-yl 1-pentyl-1H-              7222  I
 indole-3-carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-                  7225  I
 fluoropentyl)-1H-indole-3-
 carboxylate).
Alpha-ethyltryptamine..............            7249  I
Ibogaine...........................            7260  I

[[Page 53925]]

 
CP-47,497 (5-(1,1-Dimethylheptyl)-2-           7297  I
 [(1R,3S)-3-hydroxycyclohexyl-
 phenol).
CP-47,497 C8 Homologue (5-(1,1-                7298  I
 Dimethyloctyl)-2-[(1R,3S)3-
 hydroxycyclohexyl-phenol).
Lysergic acid diethylamide.........            7315  I
2C-T-7 (2,5-Dimethoxy-4-(n)-                   7348  I
 propylthiophenethylamine.
Marihuana..........................            7360  I
Parahexyl..........................            7374  I
Mescaline..........................            7381  I
2C-T-2 (2-(4-Ethylthio-2,5-                    7385  I
 dimethoxyphenyl) ethanamine ).
3,4,5-Trimethoxyamphetamine........            7390  I
4-Bromo-2,5-dimethoxyamphetamine...            7391  I
4-Bromo-2,5-dimethoxyphenethylamine            7392  I
4-Methyl-2,5-dimethoxyamphetamine..            7395  I
2,5-Dimethoxyamphetamine...........            7396  I
JWH-398 (1-Pentyl-3-(4-chloro-1-               7398  I
 naphthoyl) indole).
3,4-Methylenedioxyamphetamine......            7400  I
5-Methoxy-3,4-                                 7401  I
 methylenedioxyamphetamine.
N-Hydroxy-3,4-                                 7402  I
 methylenedioxyamphetamine.
3,4-Methylenedioxy-N-                          7404  I
 ethylamphetamine.
3,4-Methylenedioxymethamphetamine..            7405  I
4-Methoxyamphetamine...............            7411  I
5-Methoxy-N-N-dimethyltryptamine...            7431  I
Alpha-methyltryptamine.............            7432  I
Bufotenine.........................            7433  I
Diethyltryptamine..................            7434  I
Dimethyltryptamine.................            7435  I
Psilocybin.........................            7437  I
Psilocyn...........................            7438  I
5-Methoxy-N,N-diisopropyltryptamine            7439  I
N-Ethyl-1-phenylcyclohexylamine....            7455  I
1-(1-Phenylcyclohexyl)pyrrolidine..            7458  I
1-[1-(2-                                       7470  I
 Thienyl)cyclohexyl]piperidine.
N-Benzylpiperazine.................            7493  I
4-MePPP (4-Methyl-                             7498  I
 alphapyrrolidinopropiophenone).
2C-D (2-(2,5-Dimethoxy-4-                      7508  I
 methylphenyl) ethanamine).
2C-E (2-(2,5-Dimethoxy-4-                      7509  I
 ethylphenyl) ethanamine).
2C-H 2-(2,5-Dimethoxyphenyl)                   7517  I
 ethanamine).
2C-I 2-(4-iodo-2,5-dimethoxyphenyl)            7518  I
 ethanamine).
2C-C 2-(4-Chloro-2,5-                          7519  I
 dimethoxyphenyl) ethanamine).
2C-N (2-(2,5-Dimethoxy-4-nitro-                7521  I
 phenyl) ethanamine).
2C-P (2-(2,5-Dimethoxy-4-(n)-                  7524  I
 propylphenyl) ethanamine).
2C-T-4 (2-(4-Isopropylthio)-2,5-               7532  I
 dimethoxyphenyl) ethanamine).
MDPV (3,4-                                     7535  I
 Methylenedioxypyrovalerone).
25B-NBOMe (2-(4-bromo-2,5-                     7536  I
 dimethoxyphenyl)-N-(2-
 methoxybenzyl) ethanamine).
25C-NBOMe (2-(4-chloro-2,5-                    7537  I
 dimethoxyphenyl)-N-(2-
 methoxybenzyl) ethanamine).
25I-NBOMe (2-(4-iodo-2,5-                      7538  I
 dimethoxyphenyl)-N-(2-
 methoxybenzyl) ethanamine).
Methylone (3,4-Methylenedioxy-N-               7540  I
 methylcathinone).
Butylone...........................            7541  I
Pentylone..........................            7542  I
alpha-pyrrolidinopentiophenone                 7545  I
 ([alpha]-PVP).
alpha-pyrrolidinobutiophenone                  7546  I
 ([alpha]-PBP).
AM-694 (1-(5-Fluoropentyl)-3-(2-               7694  I
 iodobenzoyl) indole).
Desomorphine.......................            9055  I
Etorphine (except HCl).............            9056  I
Codeine methylbromide..............            9070  I
Heroin.............................            9200  I
Morphine-N-oxide...................            9307  I
Normorphine........................            9313  I
Pholcodine.........................            9314  I
U-47700 (3,4-dichloro-N-[2-                    9547  I
 (dimethylamino)cyclohexyl]-N-
 methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1-                   9551  I
 dimethylamino)cyclohexylmethyl]ben
 zamide)).
Acetylmethadol.....................            9601  I
Allylprodine.......................            9602  I
Alphacetylmethadol except levo-                9603  I
 alphacetylmethadol.
Alphameprodine.....................            9604  I
Alphamethadol......................            9605  I
Betacetylmethadol..................            9607  I
Betameprodine......................            9608  I
Betamethadol.......................            9609  I
Betaprodine........................            9611  I
Dextromoramide.....................            9613  I
Dipipanone.........................            9622  I
Hydroxypethidine...................            9627  I
Noracymethadol.....................            9633  I
Norlevorphanol.....................            9634  I

[[Page 53926]]

 
Normethadone.......................            9635  I
Racemoramide.......................            9645  I
Trimeperidine......................            9646  I
1-Methyl-4-phenyl-4-                           9661  I
 propionoxypiperidine.
Tilidine...........................            9750  I
Para-Fluorofentanyl................            9812  I
3-Methylfentanyl...................            9813  I
Alpha-methylfentanyl...............            9814  I
Acetyl-alpha-methylfentanyl........            9815  I
Beta-hydroxyfentanyl...............            9830  I
Beta-hydroxy-3-methylfentanyl......            9831  I
Alpha-methylthiofentanyl...........            9832  I
3-Methylthiofentanyl...............            9833  I
Thiofentanyl.......................            9835  I
Fentanyl related-compounds as                  9850  I
 defined in 21 CFR 1308.11(h).
Methamphetamine....................            1105  II
Methylphenidate....................            1724  II
Amobarbital........................            2125  II
Pentobarbital......................            2270  II
Secobarbital.......................            2315  II
Glutethimide.......................            2550  II
Nabilone...........................            7379  II
1-Phenylcyclohexylamine............            7460  II
Phencyclidine......................            7471  II
Phenylacetone......................            8501  II
1-Piperidinocyclohexanecarbonitrile            8603  II
Alphaprodine.......................            9010  II
Dihydrocodeine.....................            9120  II
Ecgonine...........................            9180  II
Ethylmorphine......................            9190  II
Levomethorphan.....................            9210  II
Levorphanol........................            9220  II
Meperidine.........................            9230  II
Dextropropoxyphene, bulk (non-                 9273  II
 dosage forms).
Levo-alphacetylmethadol............            9648  II
Noroxymorphone.....................            9668  II
Racemethorphan.....................            9732  II
Alfentanil.........................            9737  II
Remifentanil.......................            9739  II
Sufentanil.........................            9740  II
Carfentanil........................            9743  II
Tapentadol.........................            9780  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
the manufacturing of analytical reference standards and distribution to 
their research and forensic customers. No other activities for these 
drug codes are authorized for this registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2).
    Authorization will not extend to the import of Food and Drug 
Administration-approved or non-approved finished dosage forms for 
commercial sale.

Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-17037 Filed 8-8-23; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.